For research use only. Not for therapeutic Use.
Alefacept (BG 9273) is a human lymphocyte function-associated antigen 3/immunoglobulin 1 fusion protein. Alefacept can be used for the research of chronic plaque psoriasis[1].
Catalog Number | I042180 |
CAS Number | 222535-22-0 |
Purity | ≥95% |
Reference | [1]. Mark Lebwohl, et al. An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis. Arch Dermatol. 2003 Jun;139(6):719-27. |